GSK plc Sponsored ADR
(NYSE: GSK)

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK�s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

37.970 s

-0.260 (-0.68%)
Range 37.510 - 37.970   (1.23%)
Open 37.710
Previous Close 38.230
Bid Price 3.800
Bid Volume -
Ask Price 3.810
Ask Volume -
Volume 4,004,303
Value -
Remark s
Delayed prices. Updated at 26 Jul 2025 04:00.
Data powered by
View All Events

About GSK Sp ADR

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK�s principal pharmaceutical produ...
more

Share your investing ideas
Please login to view stock data and analysis